For the week ended November 12, the Healthcare research Symphony Health Solutions reported that Qsymia prescriptions had increased by 44 percent...
Your Cheat Sheet to the top healthcare business news...
Vivus has been one of the hottest stories on the street over the past two months....
Qsymia sales have been weak in the drug's first months on the market, revealing how dependent the drug's sales are on insurer coverage...
In late September, the company introduced its weight-loss drug Qsymia, ahead of Arena Pharmaceuticals’ Belviq and Orexigen Therapeutics’ Contrave, into a market that has seen no new drugs developed in more than a decade...
Your Cheat Sheet to the top healthcare business news...
Here's how these healthcare stocks are moving now...
Worries that Vivus’ new obesity drug would not be widely covered by health insurers have been put to rest...
Your Cheat Sheet to the top healthcare business news...
Here's why these healthcare stocks are moving now...
Your Cheat Sheet to the top healthcare business news...
Your Cheat Sheet to the top healthcare business news...
Here's why these health stocks are moving now...
The Nasdaq was down 0.65 percent on the day and strands at 3,116. These healthcare stocks helped to move the exchange...
Your Cheat Sheet to the top healthcare business news...